<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35242986</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>05</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">2352-5878</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>JPRAS open</Title>
          <ISOAbbreviation>JPRAS Open</ISOAbbreviation>
        </Journal>
        <ArticleTitle>What are the likely causes of breast implant associated anaplastic large cell lymphoma (BIA-ALCL)?</ArticleTitle>
        <Pagination>
          <StartPage>34</StartPage>
          <EndPage>42</EndPage>
          <MedlinePgn>34-42</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jpra.2021.11.006</ELocationID>
        <Abstract>
          <AbstractText>Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a CD30-positive, anaplastic lymphoma kinase-negative T-cell lymphoma. Where implant history is known, all confirmed cases to date have occurred in patients with exposure to textured implants. The etiopathogenesis of BIA-ALCL is likely to be multifactorial, with current evidence-based theories recognising the combination of chronic infection in setting of textured implants, gram-negative biofilm formation, chronic inflammation, host genetics (e.g. JAK/STAT, p53) and time in tumorigenesis. Proposed triggers for the development of malignancy are mechanical friction, silicone implant shell particulates, silicone leachables and bacteria. Of these, the bacterial hypothesis has received significant attention, supported by a plausible biological model. In this model, bacteria form an adherent biofilm in the favourable environment of the textured implant surface, producing a bacterial load that elicits a chronic inflammatory response. Bacterial antigens, primarily of gram-negative origin, may trigger innate immunity and induce T-cell proliferation with subsequent malignant transformation in genetically susceptible individuals. Future research, investigating BIA-ALCL genetic mutations and immunological modulation with Gram-negative biofilm in BIA-ALCL models is warranted to establish a unifying theory for the aetiology of BIA-ALCL.</AbstractText>
          <CopyrightInformation>© 2022 The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lajevardi</LastName>
            <ForeName>Sepehr S</ForeName>
            <Initials>SS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Plastic, Reconstructive &amp; Maxillofacial Surgery - Macquarie University, NSW, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rastogi</LastName>
            <ForeName>Pratik</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Plastic, Reconstructive &amp; Maxillofacial Surgery - Macquarie University, NSW, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Isacson</LastName>
            <ForeName>Daniel</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Plastic, Reconstructive &amp; Maxillofacial Surgery - Macquarie University, NSW, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Deva</LastName>
            <ForeName>Anand K</ForeName>
            <Initials>AK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Plastic, Reconstructive &amp; Maxillofacial Surgery - Macquarie University, NSW, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>01</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>JPRAS Open</MedlineTA>
        <NlmUniqueID>101680420</NlmUniqueID>
        <ISSNLinking>2352-5878</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Antigens</Keyword>
        <Keyword MajorTopicYN="N">BIA-ALCL, Breast implant-associated anaplastic large cell lymphoma</Keyword>
        <Keyword MajorTopicYN="N">Bacterial</Keyword>
        <Keyword MajorTopicYN="N">Breast implants</Keyword>
        <Keyword MajorTopicYN="N">Lymphoma</Keyword>
        <Keyword MajorTopicYN="N">T-cells</Keyword>
      </KeywordList>
      <CoiStatement>Prof. Deva is a consultant, research coordinator, educator to Allergan, Mentor (Johnson &amp; Johnson), Sientra, Motiva and Acelity (KCI.) He has previously coordinated industry-sponsored research for these companies relating to both biofilms and breast prostheses. Dr S. Lajevardi, Dr P. Rastogi and Dr D. Isacson have no affiliations or financial interests to disclose.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>4</Day>
          <Hour>5</Hour>
          <Minute>42</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35242986</ArticleId>
        <ArticleId IdType="pmc">PMC8867047</ArticleId>
        <ArticleId IdType="doi">10.1016/j.jpra.2021.11.006</ArticleId>
        <ArticleId IdType="pii">S2352-5878(22)00001-8</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Rastogi P., Riordan E., Moon D., Deva A.K. Theories of Etiopathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Plast Reconstr Surg. 2019;143:23s–29s.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30817553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barnsley G.P., Sigurdson L.J., Barnsley S.E. Textured surface breast implants in the prevention of capsular contracture among breast augmentation patients: a meta-analysis of randomized controlled trials. Plast Reconstr Surg. 2006;117:2182–2190.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16772915</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wong C.H., Samuel M., Tan B.K., Song C. Capsular contracture in subglandular breast augmentation with textured versus smooth breast implants: a systematic review. Plast Reconstr Surg. 2006;118:1224–1236.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17016195</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ajdic D., Zoghbi Y., Gerth D., Panthaki Z.J., Thaller S. The relationship of bacterial biofilms and capsular contracture in breast implants. Aesthet Surg J. 2016;36:297–309.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5127460</ArticleId>
            <ArticleId IdType="pubmed">26843099</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>den Braber E.T., de Ruijter J.E., Smits H.T., et al.  Effect of parallel surface microgrooves and surface energy on cell growth. J Biomed Mater Res. 1995;29:511–518.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7622536</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Henderson P.W., Nash D., Laskowski M., Grant R.T. Objective Comparison of Commercially Available Breast Implant Devices. Aesthetic Plast Surg. 2015;39:724–732.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26206500</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sforza M., Zaccheddu R., Alleruzzo A., et al.  Preliminary 3-Year Evaluation of Experience With SilkSurface and VelvetSurface Motiva Silicone Breast Implants: a Single-Center Experience With 5813 Consecutive Breast Augmentation Cases. Aesthet Surg J. 2018;38:S62–S73.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5952962</ArticleId>
            <ArticleId IdType="pubmed">29040364</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu H., Jacombs A., Vickery K., et al.  Chronic biofilm infection in breast implants is associated with an increased T-cell lymphocytic infiltrate: implications for breast implant-associated lymphoma. Plast Reconstr Surg. 2015;135:319–329.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25383716</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu H., Johani K., Almatroudi A., et al.  Bacterial Biofilm Infection Detected in Breast Implant-Associated Anaplastic Large-Cell Lymphoma. Plast Reconstr Surg. 2016;137:1659–1669.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26890506</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shahriari N., Ferenczi K., Heald P.W. Breast implant-associated anaplastic large cell lymphoma: a review and assessment of cutaneous manifestations. Int J Womens Dermatol. 2017;3:140–144.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5555281</ArticleId>
            <ArticleId IdType="pubmed">28831423</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Talwalkar S.S., Miranda R.N., Valbuena J.R., et al.  Lymphomas involving the breast: a study of 106 cases comparing localized and disseminated neoplasms. Am J Surg Pathol. 2008;32:1299–1309.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18636016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blombery P., Prince H.M., Seymour J.F. Primary Breast Lymphoma-Population-Level Insights into an Infrequent but Increasingly Recognized Subtype of Lymphoma. J Natl Cancer Inst. 2017:109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28376146</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hapgood G., Savage K.J. The biology and management of systemic anaplastic large cell lymphoma. Blood. 2015;126:17–25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25869285</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Savage K.J., Harris N.L., Vose J.M., et al.  ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. Blood. 2008;111:5496–5504.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18385450</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clemens M.W., Medeiros L.J., Butler C.E., et al.  Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma. J Clin Oncol. 2016;34:160–168.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4872006</ArticleId>
            <ArticleId IdType="pubmed">26628470</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pennock N.D., White J.T., Cross E.W., et al.  T cell responses: naive to memory and everything in between. Adv Physiol Educ. 2013;37:273–283.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4089090</ArticleId>
            <ArticleId IdType="pubmed">24292902</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Turner S. An exploration into the orgins and pathogenesis of anaplastic large cell lymphoma, anaplastic lymphoma kinase (ALK)-positive Cancers 2017: 9.</Citation>
        </Reference>
        <Reference>
          <Citation>Malcolm T.I., Hodson D.J., Macintyre E.A., Turner S.D. Challenging perspectives on the cellular origins of lymphoma. Open Biol. 2016:6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5043587</ArticleId>
            <ArticleId IdType="pubmed">27683157</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lowe D.B., Storkus W.J. Chronic inflammation and immunologic-based constraints in malignant disease. Immunotherapy. 2011;3:1265–1274.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3225121</ArticleId>
            <ArticleId IdType="pubmed">21995576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burg G., Kempf W., Haeffner A., et al.  From inflammation to neoplasia: new concepts in the pathogenesis of cutaneous lymphomas. Recent Results Cancer Res. 2002;160:271–280.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12079224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Han A., Newell E.W., Glanville J., et al.  Dietary gluten triggers concomitant activation of CD4+ and CD8+ alphabeta T cells and gammadelta T cells in celiac disease. Proc Natl Acad Sci U S A. 2013;110:13073–13078.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3740842</ArticleId>
            <ArticleId IdType="pubmed">23878218</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hardy M.Y., Tye-Din J.A. Coeliac disease: a unique model for investigating broken tolerance in autoimmunity. Clin Transl Immunology. 2016;5:e112.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5133362</ArticleId>
            <ArticleId IdType="pubmed">27990287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lechner M.G., Megiel C., Church C.H., et al.  Survival signals and targets for therapy in breast implant-associated ALK–anaplastic large cell lymphoma. Clin Cancer Res. 2012;18:4549–4559.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22791880</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sansone P., Bromberg J. Targeting the interleukin-6/Jak/stat pathway in human malignancies. J Clin Oncol. 2012;30:1005–1014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3341105</ArticleId>
            <ArticleId IdType="pubmed">22355058</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao S.P., Mark K.G., Leslie K., et al.  Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. J Clin Invest. 2007;117:3846–3856.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2096430</ArticleId>
            <ArticleId IdType="pubmed">18060032</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kadin M.E., Deva A., Xu H., et al.  Biomarkers provide clues to early events in the pathogenesis of breast implant-associated anaplastic large cell lymphoma. Aesthet Surg J. 2016;36:773–781.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26979456</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolfram D., Rabensteiner E., Grundtman C., et al.  T regulatory cells and TH17 cells in peri-silicone implant capsular fibrosis. Plast Reconstr Surg. 2012;129:327e–337e.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22286447</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fleury E.F., Rego M.M., Ramalho L.C., et al.  Silicone-induced granuloma of breast implant capsule (SIGBIC): similarities and differences with anaplastic large cell lymphoma (ALCL) and their differential diagnosis. Breast Cancer (Dove Med Press) 2017;9:133–140.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5354541</ArticleId>
            <ArticleId IdType="pubmed">28331364</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mazzocchi M., Dessy L.A., Corrias F., Scuderi N. A clinical study of late seroma in breast implantation surgery. Aesthetic Plast Surg. 2012;36:97–104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21638164</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ravi-Kumar S., Sanaei O., Vasef M., Rabinowitz I., Fekrazad M.H. Anaplastic large cell lymphoma associated with breast implants. World J Plast Surg. 2012;1:30–35.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4344963</ArticleId>
            <ArticleId IdType="pubmed">25734041</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cappellano G., Ploner C., Lobenwein S., et al.  Immunophenotypic characterization of human T cells after in vitro exposure to different silicone breast implant surfaces. PLoS ONE. 2018;13</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5805229</ArticleId>
            <ArticleId IdType="pubmed">29420643</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mladick R.A. Significance of Staphylococcus epidermidis causing subclinical infection. Plast Reconstr Surg. 2005;115:1426–1427. author reply 27-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15809613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clinton A., Carter T. Chronic Wound Biofilms: pathogenesis and Potential Therapies. Lab Med. 2015;46:277–284.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26489671</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Loch-Wilkinson A., Beath K.J., Knight R.J.W., et al.  Breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand: high-Surface-Area Textured Implants Are Associated with Increased Risk. Plast. Reconstr. Surg. 2017;140:645–654.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28481803</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deva A.K. Response to "breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): why the search for an infectious etiology may be irrelevant". Aesthetic Surgery Journal. 2017;37:NP122–NNP28.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29025239</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Loch-Wilkinson A., Beath K.J., Knight R.J.W., et al.  Breast Implant-Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand: high-Surface-Area Textured Implants Are Associated with Increased Risk. Plast Reconstr Surg. 2017;140:645–654.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28481803</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Myint A.A., Lee W., Mun S., et al.  Influence of membrane surface properties on the behavior of initial bacterial adhesion and biofilm development onto nanofiltration membranes. Biofouling. 2010;26:313–321.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20087803</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Teughels W., Van Assche N., Sliepen I., Quirynen M. Effect of material characteristics and/or surface topography on biofilm development. Clin Oral Implants Res. 2006;17(Suppl 2):68–81.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16968383</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jacombs A., Tahir S., Hu H., et al.  In vitro and in vivo investigation of the influence of implant surface on the formation of bacterial biofilm in mammary implants. Plast Reconstr Surg. 2014;133:471e–480e.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24675200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ryan M.P., Adley C.C. Ralstonia spp.: emerging global opportunistic pathogens. Eur J Clin Microbiol Infect Dis. 2014;33:291–304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24057141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pajkos A., Deva A.K., Vickery K., et al.  Detection of subclinical infection in significant breast implant capsules. Plast Reconstr Surg. 2003;111:1605–1611.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12655204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rieger U.M., Mesina J., Kalbermatten D.F., et al.  Bacterial biofilms and capsular contracture in patients with breast implants. Br J Surg. 2013;100:768–774.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23468161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schreml S., Heine N., Eisenmann-Klein M., Prantl L. Bacterial colonization is of major relevance for high-grade capsular contracture after augmentation mammaplasty. Ann Plast Surg. 2007;59:126–130.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17667403</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Virden C.P., Dobke M.K., Stein P., Parsons C.L., Frank D.H. Subclinical infection of the silicone breast implant surface as a possible cause of capsular contracture. Aesthetic Plast Surg. 1992;16:173–179.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1570781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Galdiero M., Larocca F., Iovene M.R., et al.  Microbial Evaluation in Capsular Contracture of Breast Implants. Plast Reconstr Surg. 2018;141:23–30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29280857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang F., Meng W., Wang B., Qiao L. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett. 2014;345:196–202.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23981572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang M.Y., Liu X.F., Gao X.Z. Helicobacter pylori virulence factors in development of gastric carcinoma. Future Microbiol. 2015;10:1505–1516.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26346770</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Munford R.S. Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant? Infect Immun. 2008;76:454–465.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2223455</ArticleId>
            <ArticleId IdType="pubmed">18086818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jappe U. Superantigens and their association with dermatological inflammatory disease: facts and hypotheses. Acta Derm Venereol. 2000;20:321–328.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11200827</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Irwin M.J., Hudson K.R., Ames K.T., Fraser J.D., Gascoigne N.R. T-cell receptor beta-chain binding to enterotoxin superantigens. Immunol Rev. 1993;131:61–78.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8486394</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kadin M.E., Morgan J., Xu H., Glicksman C.A. CD30+ T Cells in Late Seroma May Not Be Diagnostic of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Aesthet Surg J. 2017;37:771–775.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28402493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morrissey D., O'Sullivan G.C., Tangney M. Tumour targeting with systemically administered bacteria. Curr Gene Ther. 2010;10:3–14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20156191</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Myckatyn T.M., Parikh R.P. Discussion: breast Implant-Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand: high-Surface-Area Textured Implants Are Associated with Increased Risk. Plast Reconstr Surg. 2017;140:655–658.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28953712</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blombery P., Thompson E.R., Jones K., et al.  Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma. Haematologica. 2016;101:e387–e390.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5060038</ArticleId>
            <ArticleId IdType="pubmed">27198716</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crescenzo R., Abate F., Lasorsa E., et al.  Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma. Cancer Cell. 2015;27:516–532.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5898430</ArticleId>
            <ArticleId IdType="pubmed">25873174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Di Napoli A., Jain P., Duranti E., et al.  Targeted next generation sequencing of breast implant-associated anaplastic large cell lymphoma reveals mutations in JAK/STAT signalling pathway genes, TP53 and DNMT3A. Br J Haematol. 2018;180:741–744.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27859003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Letourneau A., Maerevoet M., Milowich D., et al.  Dual JAK1 and STAT3 mutations in a breast implant-associated anaplastic large cell lymphoma. Virchows Arch. 2018</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29637270</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oishi N., Brody G.S., Ketterling R.P., et al.  Genetic subtyping of breast implant-associated anaplastic large cell lymphoma. Blood. 2018</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6073323</ArticleId>
            <ArticleId IdType="pubmed">29921615</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pastorello R.G., D'Almeida Costa F., Osorio C., et al.  Breast implant-associated anaplastic large cell lymphoma in a Li-FRAUMENI patient: a case report. Diagn Pathol. 2018;13:10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5784673</ArticleId>
            <ArticleId IdType="pubmed">29370815</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee Y.S., Filie A., Arthur D., Fojo A.T., Jaffe E.S. Breast implant-associated anaplastic large cell lymphoma in a patient with Li-Fraumeni syndrome. Histopathology. 2015;67:925–927.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4644504</ArticleId>
            <ArticleId IdType="pubmed">25974645</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Laurent C., Nicolae A., Laurent C., et al.  Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL. Blood. 2020;135:360–370.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7059458</ArticleId>
            <ArticleId IdType="pubmed">31774495</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Flex E., Petrangeli V., Stella L., et al.  Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia. J Exp Med. 2008;205:751–758.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2292215</ArticleId>
            <ArticleId IdType="pubmed">18362173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blombery P., Thompson E., Ryland G.L., et al.  Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphoma. Oncotarget. 2018;9:36126–36136.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6281423</ArticleId>
            <ArticleId IdType="pubmed">30546832</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Los-de Vries G.T., de Boer M., van Dijk E., et al.  Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphoma. Blood. 2020;136:2927–2932.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33331925</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
